CA Stock MarketDetailed Quotes

DRUG Bright Minds Biosciences Inc

Watchlist
  • 58.370
  • +2.860+5.15%
15min DelayMarket Closed Dec 13 15:13 ET
407.10MMarket Cap-66.33P/E (TTM)

About Bright Minds Biosciences Inc Company

Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.

Company Profile

SymbolDRUG
Company NameBright Minds Biosciences Inc
Founded2019
MarketCNQ
Employees1
Fiscal Year Ends09-30
Address19 Vestry Street
CityNew York
CountryUnited States of America
Zip Code10013
Phone+1 647 865-8622

Company Executives

  • Name
  • Position
  • Salary
  • Ian McDonald
  • President, Chief Executive Officer and Director
  • 626.18K
  • Dr. Mark A. Smith
  • Chief Medical Officer
  • 450.92K
  • Dr. Jan Pedersen, M.Sc.
  • Director and Chief Science Officer
  • 799.72K
  • Ryan E. Cheung
  • Chief Financial Officer
  • 120.00K
  • Dr. David M. Weiner, M.D.
  • Independent Director
  • 22.04K
  • Nils Christian Bottler
  • Independent Director
  • 7.69K
  • Jeremy Fryzuk
  • Independent Director
  • 7.69K